LuciAfa 40mg Tablet (Afatinib) – Long Product Description

Product Overview

LuciAfa 40mg Tablet contains Afatinib 40mg, a targeted oral anticancer medication used to treat certain types of non-small cell lung cancer (NSCLC) with specific epidermal growth factor receptor (EGFR) mutations. Afatinib belongs to the class of medicines known as tyrosine kinase inhibitors (TKIs) and works by blocking abnormal signals that promote the growth and spread of cancer cells. By targeting these pathways, LuciAfa helps slow tumor progression and supports more effective, personalized cancer treatment.

Manufactured by Lucius Pharmaceuticals, LuciAfa 40mg is supplied in a pack of 30 tablets, offering a convenient one-month treatment supply when taken as prescribed by a healthcare professional.

Key Features

• Brand Name: LuciAfa 40mg Tablet
• Generic Name: Afatinib
• Strength: 40mg
• Dosage Form: Oral Tablet
• Therapeutic Class: Tyrosine Kinase Inhibitor (TKI)
• Manufacturer: Lucius Pharmaceuticals
• Pack Size: 30 Tablets
• Prescription Required: Yes

Indications

LuciAfa 40mg Tablet is indicated for the treatment of adults with:

• EGFR mutation-positive metastatic or locally advanced non-small cell lung cancer (NSCLC).
• Advanced squamous NSCLC that has progressed following platinum-based chemotherapy, when considered appropriate by the treating oncologist.

The use of this medicine should be based on a confirmed diagnosis and, where applicable, molecular testing to determine EGFR mutation status.

How LuciAfa 40mg Works

Afatinib is an irreversible inhibitor of the ErbB family of receptors, including EGFR (ErbB1), HER2 (ErbB2), and ErbB4. These receptors are involved in signaling pathways that regulate cell growth and division. In cancers driven by abnormal EGFR activity, these signals become overactive, leading to uncontrolled tumor growth.

LuciAfa permanently blocks these receptors, helping to reduce cancer cell multiplication, inhibit tumor growth, and slow disease progression in eligible patients.

Dosage and Administration

The recommended dose is one 40mg tablet once daily, or as directed by your oncologist.

For best results:

• Take the tablet on an empty stomach.
• Swallow it whole with water.
• Take it at least 1 hour before or 2 hours after meals.
• Take the medicine at the same time each day.

Do not crush, chew, or split the tablet. Your doctor may adjust the dose if side effects occur or based on your individual treatment response.

Benefits of LuciAfa 40mg Tablet

• Targets EGFR-mutated lung cancer cells with precision.
• Helps slow the growth and spread of cancer.
• Convenient once-daily oral treatment.
• May delay disease progression in eligible patients.
• Supports personalized cancer therapy based on genetic testing.
• Can be taken at home under medical supervision.

Possible Side Effects

Like all medicines, LuciAfa 40mg Tablet may cause side effects. Common side effects include:

• Diarrhea
• Skin rash
• Acne-like eruptions
• Dry skin
• Mouth ulcers
• Nail inflammation
• Decreased appetite
• Nausea
• Vomiting
• Fatigue

Contact your healthcare provider immediately if you experience severe diarrhea, breathing difficulties, persistent cough, severe skin reactions, eye pain or vision changes, or symptoms of liver problems.

Warnings and Precautions

Before taking LuciAfa 40mg Tablet, inform your doctor if you have:

• Liver disease
• Kidney impairment
• Lung disease
• Heart conditions
• Eye disorders
• A history of severe allergic or skin reactions

Afatinib may cause harm to an unborn baby. Effective contraception should be used during treatment and for the recommended period after the final dose. Breastfeeding should generally be avoided during treatment unless advised otherwise by your physician.

Drug Interactions

Certain medications, including prescription medicines, over-the-counter drugs, vitamins, and herbal supplements, may interact with Afatinib. Inform your healthcare provider about all medicines you are taking before starting treatment to help minimize the risk of interactions.

Storage Instructions

• Store below 30°C.
• Keep the tablets in the original packaging.
• Protect from heat, moisture, and direct sunlight.
• Keep out of reach of children and pets.

Pack Information

• Brand: LuciAfa
• Generic Name: Afatinib
• Strength: 40mg
• Dosage Form: Tablet
• Pack Size: 30 Tablets
• Manufacturer: Lucius Pharmaceuticals

Disclaimer

LuciAfa 40mg Tablet (Afatinib) is a prescription-only medication intended for use under the supervision of a qualified oncologist. It should only be used according to your healthcare provider’s instructions. Treatment outcomes vary depending on the patient’s condition, cancer type, genetic profile, and response to therapy. Regular medical monitoring and follow-up are essential throughout treatment.